Skip to main content

Advertisement

Log in

Global prevalence of hypomagnesemia in type 2 diabetes mellitus – a comprehensive systematic review and meta-analysis of observational studies

  • Meta- Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Hypomagnesemia, characterized by low magnesium levels, has been implicated in the pathophysiology of Type 2 Diabetes Mellitus (T2DM). This meta-analysis aims to provide a comprehensive assessment of hypomagnesemia prevalence in individuals with T2DM as well as its potential implications for diabetes management and complications.

Methods

We conducted a comprehensive systematic review and meta-analysis using databases like PubMed, Google Scholar, Science Direct, and Research Gate to identify relevant studies between January 2008 and August 2023. We focused on observational studies related to serum magnesium levels and Type 2 Diabetes in individuals aged 19 and older. Newcastle Ottawa tool was used for quality assessment. A random effect meta-analysis was performed to calculate the prevalence of hypomagnesemia in T2DM.

Results

We identified a total of 671 studies, and after screening 383 abstracts and full texts by two independent reviewers, we identified 19 eligible studies encompassing 4192 patients diagnosed with T2DM. The mean age was 55.4 (SD, 4.39) years with a mean HbA1C level of 8.01. The pooled prevalence of hypomagnesemia in T2DM was 32% (95% CI: 22–36%) out of 4192 cases. On subgroup analysis, the prevalence of hypomagnesemia in male and female were 19.8% and 20.1%, respectively. Geographically, Asia had the highest prevalence of hypomagnesemia with 31.9% (95% CI: 24–41.1%).

Conclusion

This meta-analysis highlights a significant prevalence of hypomagnesemia in individuals with T2DM, emphasizing the need for further investigation due to the intricate nature of the association between serum magnesium levels and T2DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. H. King, R.E. Aubert, W.H. Herman, Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9), 1414–1431 (1998).

    Article  CAS  PubMed  Google Scholar 

  2. L.M.M. Gommers, J.G.J. Hoenderop, R.J.M. Bindels, J.H.F. De Baaij, Hypomagnesemia in type 2 diabetes: A vicious circle? Diabetes [Internet]. 65(1), 3–13 (2023). https://diabetesjournals.org/diabetes/article/65/1/3/34908/Hypomagnesemia-in-Type-2-Diabetes-A-Vicious-Circle.

  3. M. Barbagallo, L.J. Dominguez, Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch. Biochem. Biophys. 458(1), 40–47 (2007).

    Article  CAS  PubMed  Google Scholar 

  4. G. Liamis, E. Liberopoulos, F. Barkas, M. Elisaf, Diabetes mellitus and electrolyte disorders. World J. Clin. Cases 2(10), 488–496 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  5. W.H.L. Kao, A.R. Folsom, F.J. Nieto, J.P. Mo, R.L. Watson, F.L. Brancati, Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The atherosclerosis risk in communities study. Arch. Intern. Med. [Internet] 159(18), 2151 (2023). https://doi.org/10.1001/archinte.159.18.2151.

    Article  Google Scholar 

  6. P.C.T. Pham, P.M.T. Pham, S.V. Pham, J.M. Miller, P.T.T. Pham, Hypomagnesemia in patients with type 2 diabetes. Clin. J. Am. Soc. Nephrol. [Internet] 2(2), 366–373 (2023). https://journals.lww.com/01277230-200703000-00033.

  7. G.A. Wells, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. University of Ottawa, Room A 3227 (2011): 451.

  8. R. Suurmond, H. Van Rhee, T. Hak, Introduction, comparison, and validation of Meta‐Essentials: A free and simple tool for meta‐analysis. Res. Synth. Methods [Internet] 8(4), 537–553 (2023). https://doi.org/10.1002/jrsm.1260. Available from https://onlinelibrary.wiley.com/doi/.

  9. A. Dasgupta, D. Sarma, U.K. Saikia, Hypomagnesemia in type 2 diabetes mellitus. Indian J. Endocrinol. Metab. [Internet] 16(6), 1000 (2023). https://journals.lww.com/indjem/fulltext/2012/16060/hypomagnesemia_in_type_2_diabetes_mellitus.24.aspx.

  10. S.B. Nayyar, H.S. Brar, S. Kukreja, K. Kaur, Study of serum magnesium level in type 2 diabetes mellitus with nephropathy. Int J Adv Med [Internet]. 2019 Jul 24 [cited 6(4), 1145–1150 (2023). https://www.ijmedicine.com/index.php/ijam/article/view/1466.

  11. P. Kumar, S. Bhargava, P.K. Agarwal, A. Garg, A. Khosla. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J. Fam. Med. Prim. Care [Internet]. 2019 May [cited 8(5), 1671–1677 (2023). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559114/.

  12. P. Dwipayana, M.R. Saraswati, W. Gotera, A.A.G. Budhiarta, K. Suastika, S. Malik, et al. Hypomagnesemia is a risk factor for metabolic syndrome and type 2 diabetes mellitus in native Balinese. Fam. Med. Community Health [Internet]. 2013 Mar 1 [cited 2023 Sep 18];1(1). Available from: https://fmch.bmj.com/content/1/1/14.

  13. R. Sangroula, Fasting serum magnesium level and its association with type 2 diabetes mellitus and its chronic complications. J. Inst. Med. Nepal 43, 97–101 (2022).

    Google Scholar 

  14. T. Azeez, O. Sonuga, Hypomagnesemia as a cardiometabolic risk marker in type 2 diabetes mellitus: Implications for Sub-Saharan Africa. Ann. Clin. Cardiol. [Internet]. 2021 [cited 3(1), 29 (2023). http://www.onlineacc.org/text.asp?2021/3/1/29/317104.

  15. T. Adebayo, A. Ajayi, S. Shoyinka, F. Oyetunji, A. Ajetunmobi, O. Olaniyan, Assessment of magnesium n type II diabetes mellitus and its correlation to glycated haemoglobin. Life Sci. ume 2, 30–36 (2022).

    Google Scholar 

  16. M.M. Noor, Q. Nazir, T.M. Khan, S. Gillani, M.A. Abbasi, A. Rauf et al. Association between low serum magnesium level and type 2 diabetes mellitus in abbottabad. J. Ayub. Med. Coll. Abbottabad. 31(2), 226–229 (2019).

    PubMed  Google Scholar 

  17. M.U. Siddiqui, I. Ali, M. Zakariya, S.P. Asghar, M.R. Ahmed, G.H. Ibrahim. FREQUENCY OF HYPOMAGNESEMIA IN PATIENTS WITH UNCONTROLLED TYPE II DIABETES MELLITUS: Hypomagnesemia in Type 2 Diabetes Mellitus. Pak. Armed Forces Med. J. [Internet]. 2016 Dec 31 [cited 66(6), 845–850 (2023). https://pafmj.org/index.php/PAFMJ/article/view/1025.

  18. M. Hasan, S. Sultan, S. Ashfaq, S. Irfan, Hypomagnesemia in type II diabetes mellitus patients; an experience from a tertiary care center. Ann. PIMS 13, 146–150 (2017).

    Google Scholar 

  19. K. Alswat, Type 2 diabetes control and complications and their relation to serum magnesium level. Arch Med Sci AMS [Internet]. 2021 Mar 18 [cited 18(2), 307–313 (2023). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924817/.

  20. Y. Rao, D.R. Vanamali. Serum magnesium levels in type 2 diabetes. Int J Res Med Sci. 2016 Jan 1;

  21. O. Odusan, O. Familoni, A. Odewabi, A. Idowu, A. Adekolade, Patterns and correlates of serum magnesium levels in subsets of type 2 diabetes mellitus patients in Nigeria. Indian J. Endocrinol. Metab. 21, 439 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. R. Paladiya, A. Pitliya, A. Choudhry, D. Kumar, S. Ismail, A. Mohammed, et al. Association of low magnesium level with duration and severity of type 2 diabetes. Cureus. 2021 May 27;13.

  23. Hamarshih M, Hamshari S, Nazzal Z, Snobar F, Mletat R, Abu-Mazen O, et al. Hypomagnesemia and Poor Glycemic Control among Type 2 Diabetic Patients: A Cross-Sectional Study. Indian Journal of Endocrinology and Metabolism [Internet]. 2022;26(6). Available from: https://journals.lww.com/indjem/fulltext/2022/11000/hypomagnesemia_and_poor_glycemic_control_among.12.aspx.

  24. A. Lecube, J.A. Baena-Fustegueras, J.M. Fort, D. Pelegrí, C. Hernández, R. Simó. Diabetes is the main factor accounting for hypomagnesemia in obese subjects. PLOS ONE [Internet]. 2012 Jan 24 [cited 7(1), e30599 (2023). https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030599.

  25. D.S.S. Antin, D.M. Kashinkunti, D.A.V. Kataria, D. Dhananjaya, D.S. Alevoor. A cross sectional study of fasting serum magnesium levels in the patients with type 2 diabetes mellitus and its relation to diabetic complications. In 2014. Available from: https://www.semanticscholar.org/paper/A-Cross-Sectional-Study-of-Fasting-Serum-Magnesium-Antin-Kashinkunti/20bac9323008517456c34af67fc9a1bf08003bba.

  26. F. Waanders, R.P.F. Dullaart, M.J. Vos, S.H. Hendriks, H. van Goor, H.J.G. Bilo et al. Hypomagnesaemia and its determinants in a contemporary primary care cohort of persons with type 2 diabetes. Endocrine 67(1), 80–86 (2020).

    Article  CAS  PubMed  Google Scholar 

  27. E. Kocyigit, M. Akturk, E. Koksal, Relationships between serum and dietary magnesium, calcium, and metabolic parameters in women with type 2 diabetes mellitus. Clin. Nutr. ESPEN 54, 304–310 (2023).

    Article  PubMed  Google Scholar 

  28. L.M. Resnick, R.K. Gupta, H. Gruenspan, J.H. Laragh, Intracellular free magnesium in hypertension: relation to peripheral insulin resistance. J. Hypertens. Suppl. J. Int Soc. Hypertens. 6(4), S199–S201 (1988).

    Article  CAS  Google Scholar 

  29. F. Liao, A.R. Folsom, F.L. Brancati, Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 136(3), 480–490 (1998).

    Article  CAS  PubMed  Google Scholar 

  30. P. McNair, C. Christiansen, S. Madsbad, E. Lauritzen, O. Faber, C. Binder et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes 27(11), 1075–1077 (1978).

    Article  CAS  PubMed  Google Scholar 

  31. R. Lopez-Ridaura, W.C. Willett, E.B. Rimm, S. Liu, M.J. Stampfer, J.E. Manson et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 27(1), 134–140 (2004).

    Article  CAS  PubMed  Google Scholar 

  32. Y. Song, J.E. Manson, J.E. Buring, S. Liu, Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27(1), 59–65 (2004).

    Article  PubMed  Google Scholar 

  33. R.M. van Dam, F.B. Hu, L. Rosenberg, S. Krishnan, J.R. Palmer, Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care 29(10), 2238–2243 (2006).

    Article  PubMed  Google Scholar 

  34. A. Hatwal, A.S. Gujral, R.P. Bhatia, J.K. Agrawal, H.S. Bajpai, Association of hypomagnesemia with diabetic retinopathy. Acta Ophthalmol. (Copenh) 67(6), 714–716 (1989).

    Article  CAS  PubMed  Google Scholar 

  35. F.J. Rodriguez, A.L. Folpe, C. Giannini, A. Perry, athology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol (Berl) [Internet]. 2012 Mar [cited 123(3), 295–319 (2023). http://link.springer.com/10.1007/s00401-012-0954-z.

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by A.P., V.B., M.B.P., Suraj, A.D., A.P. and S.N. The first draft of the manuscript was written by A.P. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Srivatsa Surya Vasudevan.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethics approval

This systematic review is based on published data from literature and therefore does not involve active patient participation in the design, conduct, report or dissemination plans of the research. Therefore, it does not need ethical approval or consent for participation.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pitliya, A., Vasudevan, S.S., Batra, V. et al. Global prevalence of hypomagnesemia in type 2 diabetes mellitus – a comprehensive systematic review and meta-analysis of observational studies. Endocrine (2023). https://doi.org/10.1007/s12020-023-03670-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12020-023-03670-7

Keywords

Navigation